Product Information
ADZENYS XR-ODT 6.3 MG TABLET is a brand product labeled by Neos Therapeutics Brands, LLC, priced at $19.2089 per EA under NDC 70165001030. Its NADAC has been published 515 times since Nov 23, 2016.
FDA first approved this application on Jan 27, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
6.3 mg/1
Manufacturer
Neos Therapeutics Brands, LLCNDC
70165001030
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMPHETAMINEApproval Type
New Drug (NDA)
FDA Application
NDA204326FDA Approved
1/27/2016
TE Code
AB
On Market Since
2/16/2016
Pharmacological Classes
Price Statistics
The NADAC for ADZENYS XR-ODT 6.3 MG TABLET has been published 515 times since Nov 23, 2016, and over the history we have for it it has risen 121.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.2089 per EA |
|---|---|
| All-time high | $19.3856 (Mar 11, 2026) |
| All-time low | $8.6589 (Nov 23, 2016) |
| 52-week high | $19.3856 |
| 52-week low | $19.1983 |
| Median price | $13.8797 |
| Average price | $13.6729 |
| Largest weekly change | +14.9% (Aug 13, 2025) |
| Weeks tracked | 515 |
| Tracking since | Nov 23, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Neos Therapeutics Brands, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amphetamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ADZENYS XR-ODT 6.3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ADZENYS XR-ODT 6.3 MG TABLET, manufactured by Neos Therapeutics Brands, LLC, is $19.2089 per EA (NDC 70165001030), effective Sep 30, 2026.
How has the price of ADZENYS XR-ODT 6.3 MG TABLET changed over time?
Over the history we have for it, the NADAC for ADZENYS XR-ODT 6.3 MG TABLET has risen 121.8%. It has been tracked across 515 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for ADZENYS XR-ODT 6.3 MG TABLET?
Since Nov 23, 2016, the NADAC for ADZENYS XR-ODT 6.3 MG TABLET has ranged from a low of $8.6589 (Nov 23, 2016) to a high of $19.3856 (Mar 11, 2026), with a median of $13.8797 per EA.
Are there cheaper alternatives to ADZENYS XR-ODT 6.3 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMPHETAMINE ER 6.3 MG ODT, is $16.0732 per EA — about 16% below ADZENYS XR-ODT 6.3 MG TABLET.
Who manufactures ADZENYS XR-ODT 6.3 MG TABLET?
ADZENYS XR-ODT 6.3 MG TABLET (NDC 70165001030) is labeled by Neos Therapeutics Brands, LLC, and CMS classifies it as a brand product.